Literature DB >> 16227576

Caspase-mediated specific cleavage of BubR1 is a determinant of mitotic progression.

Mijin Kim1, Katie Murphy, Fang Liu, Sharon E Parker, Melissa L Dowling, Wesley Baff, Gary D Kao.   

Abstract

The fidelity of chromosomal duplication is monitored by cell cycle checkpoints operational during mitosis. One such cell cycle delay is invoked by microtubule-targeting agents such as nocodazole or paclitaxel (Taxol) and is mediated by mitotic checkpoint proteins that include BubR1. Relatively little is known about the regulation of expression and stability of BubR1 (or other checkpoint proteins) and how these factors dictate the durability of the cell cycle delay. We report here that treatment of HeLa cells with spindle-disrupting agents resulted in caspase activation and precipitated the cleavage of BubR1. This mechanism ultimately leads to reduced levels of full-length protein, which are accompanied by abrogation of the mitotic block; the checkpoint abrogation is substantially accelerated by inhibition of de novo protein synthesis. In contrast, inhibition of caspase activity blocked BubR1 degradation and prolonged mitosis. To confirm a direct link between caspase activity and BubR1 protein expression, we identified by site-directed mutagenesis the specific caspase cleavage sites cleaved after exposure to paclitaxel. Surprisingly, BubR1 has two sites of cleavage: primarily at Asp607/Asp610 and secondarily at Asp576/Asp579. BubR1 mutated at both locations (BubR1Delta579Delta610) was resistant to paclitaxel-induced degradation. Expression of BubR1Delta579Delta610 augmented the mitotic delay induced by spindle disruption in transfected cells as well as in clones engineered to inducibly express the mutant protein upon exposure to doxycycline and ultimately led to increased aneuploidy. Underscoring the importance of these caspase cleavage sites, both tetrapeptide motifs are identified in the amino acid sequences of human, mouse, chicken, and Xenopus BubR1. These results are potentially the first to link the control of the stability of a key mitotic checkpoint protein to caspase activation, a regulatory pathway that may be involved in killing defective cells and that has been evolutionarily conserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227576      PMCID: PMC1265846          DOI: 10.1128/MCB.25.21.9232-9248.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1.

Authors:  Z Tang; R Bharadwaj; B Li; H Yu
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

Review 2.  Exit from mitosis: spindle pole power.

Authors:  M A Hoyt
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

Review 3.  Caspases, apoptosis and aging.

Authors:  Jian-Hua Zhang; Yingpei Zhang; Brian Herman
Journal:  Ageing Res Rev       Date:  2003-10       Impact factor: 10.895

4.  BUBR1 phosphorylation is regulated during mitotic checkpoint activation.

Authors:  W Li; Z Lan; H Wu; S Wu; J Meadows; J Chen; V Zhu; W Dai
Journal:  Cell Growth Differ       Date:  1999-11

Review 5.  The mitotic checkpoint: a signaling pathway that allows a single unattached kinetochore to inhibit mitotic exit.

Authors:  Gordon K Chan; Tim J Yen
Journal:  Prog Cell Cycle Res       Date:  2003

Review 6.  Segregating sister genomes: the molecular biology of chromosome separation.

Authors:  Kim Nasmyth
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

7.  Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.

Authors:  Tamotsu Sudo; Masayuki Nitta; Hideyuki Saya; Naoto T Ueno
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  Caspase-mediated specific cleavage of human histone deacetylase 4.

Authors:  Fang Liu; Melissa Dowling; Xiang-Jiao Yang; Gary D Kao
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

9.  Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.

Authors:  Geert J P L Kops; Daniel R Foltz; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

10.  Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2.

Authors:  V Sudakin; G K Chan; T J Yen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

View more
  27 in total

1.  BubR1 is modified by sumoylation during mitotic progression.

Authors:  Feikun Yang; Liyan Hu; Cheng Chen; Jianxiu Yu; Christopher B O'Connell; Alexey Khodjakov; Michele Pagano; Wei Dai
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Sumoylated BubR1 plays an important role in chromosome segregation and mitotic timing.

Authors:  Feikun Yang; Ying Huang; Wei Dai
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

3.  Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Authors:  Jay F Dorsey; Melissa L Dowling; Mijin Kim; Ranh Voong; Lawrence J Solin; Gary D Kao
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

Review 4.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 5.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

Review 6.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

7.  High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells.

Authors:  Jewel Daniel; Jonathan Coulter; Ju-Hyung Woo; Kathleen Wilsbach; Edward Gabrielson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

8.  Stop competing, start talking!

Authors:  Luca L Fava; Andreas Villunger
Journal:  EMBO J       Date:  2014-07-25       Impact factor: 11.598

9.  Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma.

Authors:  Aaron P Havas; Kameron B Rodrigues; Anvi Bhakta; Joseph A Demirjian; Seongmin Hahn; Jack Tran; Margarethakay Scavello; Ana A Tula-Sanchez; Yi Zeng; Monika Schmelz; Catharine L Smith
Journal:  Cancer Biol Ther       Date:  2016-10-28       Impact factor: 4.742

10.  Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint.

Authors:  Daniela A Brito; Conly L Rieder
Journal:  Curr Biol       Date:  2006-06-20       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.